In recognition of World Cancer Day 2025, AstraZeneca reaffirms its commitment to advancing early detection, innovative treatments, and holistic patient care under this year’s theme, “United by Unique.
BrightHeart, a global leader in artificial intelligence (AI) solutions for obstetrics and pediatric cardiology, presented two groundbreaking studies during the oral plenary and concurrent sessions on ...
Recently granted FDA clearance, BrightHeart's AI technology represents a pivotal step forward in expanding access to expert-level care. BrightHeart invites clinicians, researchers, and industry ...